Molecular Sieves Companies
Molecular sieves are used for adsorption and separation in various industries. They manufacture molecular sieves tailored for specific applications, such as natural gas purification and petrochemical refining.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Molecular Sieves Market
-
October 2023- Sigrid Therapeutics discloses the beginning of the SHINE clinical trial for SiPore21® – a groundbreaking medical device engineered for weight control and sustained diabetes. Based on Mesoporous Silica particles (MSPs), SiPore21® signifies a landmark methodology for handling these pressing health worries. Controlled vocally in gel form, MSPs act as "molecular sieves," physically stopping digestive enzymes from relating with food, thus lowering the breakdown of fats and carbohydrates. The SHINE test, the biggest commercial prediabetes study presently, focuses on assessing the efficacy of SiPore21®. The main terminus is to evaluate whether SiPore21® treatment causes a substantial reduction in HbA1c levels, in comparison with a placebo, in obese or overweight people with advanced blood glucose levels. With positive trial outcomes, SiPore21® is prepared to be enlisted as a Class IIb medical apparatus. The landmark surfaces the method for an accessible and powerful non-pharmaceutical tool to fight the rising global diabetes and obesity health crisis. SHINE is a double-blinded, multicenter, placebo-controlled, randomized clinical investigation in line with MDR article 62. The test's subordinate terminations include a wide variety of health limits, such as lipid levels, insulin resistance, body weight, and more. SHINE looks to hire 288 male and female patients between the age group of 18 and 70 at 20 sites in three European nations. Applicants will experience a 12-week routine of verbally utilizing SiPore21® gel packs at the initiation of their primary meals, coupled with certain instructions for water intake.
Key Companies in the Molecular Sieves market include
- Tosoh Corporation (Japan)
- Arkema (France)
- BASF SE (Germany)
- Honeywell International Inc (U.S.)
- Grace & Co (U.S.)
- Zeochem AGÂ (Switzerland)
- Merck KgaA (Germany)
- Sorbead India (India)
- KNT Group (Russia)
- MolsivCN (China)
- Union Showa K.K. (Japan)
- Van Air Inc (U.S.)
Molecular Sieves Market Highlights:
Molecular Sieves Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
